Teekay Corporation Reports Fourth Quarter and Annual 2023 Results
HAMILTON, Bermuda, Feb. 22, 2024 (GLOBE NEWSWIRE) — Teekay Corporation (Teekay or the Company) (NYSE:TK) today reported results for the […]
Teck Reports Unaudited Fourth Quarter Results for 2023
VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (Teck) today […]
Teekay Tankers Ltd. Reports Fourth Quarter and Annual 2023 Results and Declares Dividend
HAMILTON, Bermuda, Feb. 22, 2024 (GLOBE NEWSWIRE) — Teekay Tankers Ltd. (Teekay Tankers or the Company) (NYSE: TNK) today reported […]
Teck Announces Base Dividend and Authorizes up to $500 Million Share Buyback
VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) announced […]
XPENG announces dealer partnerships in UAE, Egypt, Azerbaijan, Jordan and Lebanon
XPENG, a leading Chinese smart electric vehicle company, announces dealer partnerships in UAE, Egypt, Azerbaijan, Jordan and Lebanon. Through the […]
Carriage Services Announces Fourth Quarter and Full Year 2023 Results
HOUSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced results for the fourth quarter and […]
North American Construction Group Ltd. Announces Regular Quarterly Dividend
ACHESON, Alberta, Feb. 21, 2024 (GLOBE NEWSWIRE) — On February 20, 2024, the North American Construction Group Ltd. (“NACG” or […]
Alamos Gold Reports Fourth Quarter and Year-End 2023 Results
Solid Fourth Quarter Drives Record Annual Production, Revenue and Operating Cash Flow All amounts are in United States dollars, unless […]
Parsons Announces Offering Of $700.0 Million Of Convertible Senior Notes Due 2029
CHANTILLY, Va., Feb. 21, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that it intends to offer, subject […]
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
FREEHOLD, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) — Chromocell Therapeutics Corporation (NYSE American: CHRO) (“Chromocell”, “our”, “us” or the “Company”), […]
